July 25, 2007 – Varian Medical Systems recently displayed its I-Response software created by Cedara, that shows how tumors are responding to treatment at the biological level, reportedly before changes in tumor shape or size become visible, at the American Association of Physicists in Medicine (AAPM) annual meeting, July 22-26, in Minneapolis, MN.

The I-Response tool tracks changes in tumor tissue at the cellular and metabolic levels over time using sophisticated PET/CT analysis and a unique MR technique called functional diffusion mapping (fDM). This provides the potential for clinicians to monitor the impact of anti-cancer drugs and radiation therapy early in the course of treatment, so they can adapt their treatment strategies and personalize treatment plans.

For more information: www.varian.com


Additional Content

News | Radiation Therapy

Feb. 26, 2026 — GT Medical Technologies, a company focused on improving the lives of patients with brain tumors, has ...

Time February 27, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
Feature | Artificial Intelligence

Brain metastases are 10 times more common than primary brain tumors, occurring in 10 to 20% of adult patients with ...

Time September 04, 2025
arrow
News | Ultrasound Imaging

Aug. 8, 2025 — Memorial Hermann-Texas Medical Center announced it will begin using a new FDA-approved ultrasound device ...

Time August 11, 2025
arrow
Videos | Radiation Therapy

This is Reflexion’s X1 LINAC radiotherapy system on display at ASTRO 2021. It recently gained FDA clearance for standard ...

Time November 11, 2021
arrow
Subscribe Now